Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Oenema, Tjitske A ^a   Kolahian, Saeed ^a,b   Nanninga, Janke E ^a   Rieks, Daniëlle ^a   Hiemstra, Pieter S ^c   Zuyderduyn, Suzanne ^c   Halayko, Andrew J ^d   Meurs, Herman ^a   Gosens, Reinoud ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF TABRIZ   (Iran)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CIGARETTE SMOKE; CYTOKINE; I KAPPA B ALPHA; I KAPPA B KINASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PLATELET DERIVED GROWTH FACTOR AB; PROTEIN KINASE C ACTIVATOR; SC 514; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETYLCHOLINE; AUTACOID; INTERLEUKIN 6; MUSCARINIC RECEPTOR;

ARTICLE; BREATHING MUSCLE; CHOLINERGIC STIMULATION; CYTOKINE RELEASE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MUSCARINIC RECEPTOR STIMULATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE; WESTERN BLOTTING; BRONCHUS; CELL CULTURE; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; SMOKING; SMOOTH MUSCLE FIBER;

ACETYLCHOLINE; BRONCHI; CELLS, CULTURED; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SMOKING;

EID: 79551608638     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-130     Document Type: Article

References (47)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
2. Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M, Johnston SL. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 2009, 121:1-13. 10.1016/j.pharmthera.2008.09.003, 18950657.
3. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:478-485. 10.1513/pats.200802-014ET, 2645323, 18453359.
4. Profita M, Giorgi RD, Sala A, Bonanno A, Riccobono L, Mirabella F, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60:1361-1369. 10.1111/j.1398-9995.2005.00892.x, 16197467.
5. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006, 7:73. 10.1186/1465-9921-7-73, 1479816, 16684353.
6. Bateman ED, Rennard S, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009, 22:533-542. 10.1016/j.pupt.2009.06.002, 19635581.
7. Koyama S, Rennard SI, Robbins RA. Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1992, 262:L466-L471.
8. Profita M, Bonanno A, Siena L, Ferraro M, Montalbano AM, Pompeo F, et al. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur J Pharmacol 2008, 582:145-153. 10.1016/j.ejphar.2007.12.029, 18242599.
9. Sato E, Koyama S, Okubo Y, Kubo K, Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 1998, 274:L970-L979.
10. McQueen DS, Donaldson K, Bond SM, McNeilly JD, Newman S, Barton NJ, et al. Bilateral vagotomy or atropine pre-treatment reduces experimental diesel-soot induced lung inflammation. Toxicol Appl Pharmacol 2007, 219:62-71. 10.1016/j.taap.2006.11.034, 17239416.
11. Bos IS, Gosens R, Zuidhof AB, Schaafsma D, Halayko AJ, Meurs H, et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 2007, 30:653-661. 10.1183/09031936.00004907, 17537779.
12. Pera T, Zuidhof AB, Gosens R, Maarsingh H, Zaagsma J, Meurs H. Tiotropium Inhibits Inflammation and Remodeling in a Guinea Pig Model of COPD. Am J Respir Crit Care Med 2009, 179:A6328.
13. Cui YY, Zhu L, Wang H, Advenier C, Chen HZ, Devillier P. Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. Life Sci 2008, 82:949-955. 10.1016/j.lfs.2008.02.008, 18367213.
14. Trevethick M, Clarke N, Strawbridge M, Yeadon M. Inhaled muscarinic antagonists for COPD-does an anti-inflammatory mechanism really play a role?. Curr Opin Pharmacol 2009, 9:250-255. 10.1016/j.coph.2009.02.003, 19286423.
15. Chung KF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:347-354. 10.1513/pats.200504-028SR, 2713326, 16267361.
16. Zuyderduyn S, Sukkar MB, Fust A, Dhaliwal S, Burgess JK. Treating asthma means treating airway smooth muscle cells. Eur Respir J 2008, 32:265-274. 10.1183/09031936.00051407, 18669785.
17. Oltmanns U, Chung KF, Walters M, John M, Mitchell JA. Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle. Respir Res 2005, 6:74. 10.1186/1465-9921-6-74, 1187925, 16029496.
18. Racke K, Matthiesen S. The airway cholinergic system: physiology and pharmacology. Pulm Pharmacol Ther 2004, 17:181-198. 10.1016/j.pupt.2004.03.001, 15219263.
19. Gosens R, Rieks D, Meurs H, Ninaber DK, Rabe KF, Nanninga J, et al. Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J 2009, 34:1436-1443. 10.1183/09031936.00045209, 19460789.
20. Gosens R, Stelmack GL, Dueck G, McNeill KD, Yamasaki A, Gerthoffer WT, et al. Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006, 291:L523-L534. 10.1152/ajplung.00013.2006, 16617096.
21. Park H, Park SG, Kim J, Ko YG, Kim S. Signaling pathways for TNF production induced by human aminoacyl-tRNA synthetase-associating factor, p43. Cytokine 2002, 20:148-153. 10.1006/cyto.2002.1992, 12543078.
22. Bremerich DH, Warner DO, Lorenz RR, Shumway R, Jones KA. Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle. Am J Physiol 1997, 273:L775-L781.
23. Gosens R, Dueck G, Rector E, Nunes RO, Gerthoffer WT, Unruh H, et al. Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1348-L1358. 10.1152/ajplung.00346.2007, 17873004.
24. Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA, Penn RB. MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am J Physiol 1999, 277:L479-L488.
25. Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, Thomas LL. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol 1999, 65:291-298.
26. Wessler I, Kirkpatrick CJ, Racke K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 1999, 26:198-205. 10.1046/j.1440-1681.1999.03016.x, 10081614.
27. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005, 171:1096-1102. 10.1164/rccm.200409-1249OC, 15695490.
28. Kanefsky J, Lenburg M, Hai CM. Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM. Am J Respir Cell Mol Biol 2006, 34:417-425. 10.1165/rcmb.2005-0326OC, 2644203, 16339998.
29. Clarke D, Damera G, Sukkar MB, Tliba O. Transcriptional regulation of cytokine function in airway smooth muscle cells. Pulm Pharmacol Ther 2009, 22:436-445. 10.1016/j.pupt.2009.04.003, 2736328, 19393330.
30. Tetley TD. Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005, 4:607-618. 10.2174/156801005774912824, 17305517.
31. Vanaudenaerde BM, Wuyts WA, Geudens N, Dupont LJ, Schoofs K, Smeets S, et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007, 7:76-82. 10.1111/j.1600-6143.2006.01586.x, 17061983.
32. Dragon S, Rahman MS, Yang J, Unruh H, Halayko AJ, Gounni AS. IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1023-L1029. 10.1152/ajplung.00306.2006, 17189320.
33. Rahman MS, Yang J, Shan LY, Unruh H, Yang X, Halayko AJ, et al. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin Immunol 2005, 115:268-276. 10.1016/j.clim.2005.01.014, 15893694.
34. Issa R, Sorrentino R, Sukkar MB, Sriskandan S, Chung KF, Mitchell JA. Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cells. Respir Res 2008, 9:30. 10.1186/1465-9921-9-30, 2324089, 18380907.
35. Mullan CS, Riley M, Clarke D, Tatler A, Sutcliffe A, Knox AJ, et al. Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism. Am J Respir Cell Mol Biol 2008, 38:600-608. 10.1165/rcmb.2007-0082OC, 2643247, 18079491.
36. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 2006, 7:675-681. 10.2174/138945006777435263, 16787167.
37. Wong ET, Tergaonkar V. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin Sci (Lond) 2009, 116:451-465. 10.1042/CS20080502, 19200055.
38. Chen QW, Edvinsson L, Xu CB. Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells. BMC Cell Biol 2009, 10:52. 10.1186/1471-2121-10-52, 2715373, 19575782.
39. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, Wallach D, et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 1999, 19:6742-6753. 84667, 10490613.
40. Oudin S, Pugin J. Role of MAP kinase activation in interleukin-8 production by human BEAS-2B bronchial epithelial cells submitted to cyclic stretch. Am J Respir Cell Mol Biol 2002, 27:107-114.
41. O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004, 23:832-840. 10.1183/09031936.04.00116004, 15218994.
42. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005, 128:1168-1178. 10.1378/chest.128.3.1168, 16162703.
43. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002, 19:217-224. 10.1183/09031936.02.00269802, 11866001.
44. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554. 10.1056/NEJMoa0805800, 18836213.
45. Decramer M, Celli B, Burkhart D, Kesten S, Mehra S, Liu D, et al. The Effect of Tiotropium on COPD GOLD Stage II during the Four-Year UPLIFT Trial. Am J Respir Crit Care Med 2009, 179:A2466.
46. Gosens R, Zaagsma J, Grootte BM, Nelemans A, Meurs H. Acetylcholine: a novel regulator of airway smooth muscle remodelling?. Eur J Pharmacol 2004, 500:193-201. 10.1016/j.ejphar.2004.07.025, 15464033.
47. Racke K, Juergens UR, Matthiesen S. Control by cholinergic mechanisms. Eur J Pharmacol 2006, 533:57-68. 10.1016/j.ejphar.2005.12.050, 16458288.